News for Your Practice

Should genetic counselors be involved in genetic test ordering for ObGyn patients?

Yes, they can decrease inappropriate spending, says research team from Naval Medical Center San Diego


 

References

With more than 1,000 diseases for which genetic testing is available, and with the completion of the Human Genome Project, more patients are requesting genetic testing and more clinicians are utilizing such testing; it has become mainstream.1 This increased utilization has resulted in increased cost as well, say Ruzzo and colleagues, who presented research on genetic testing costs and compliance with clinical best practices at the 2017 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG).2 But, according to previous research say Ruzzo and colleagues, these costs can be quelled by involving genetic counselors in the test-ordering process.

Just how much cost savings can be achieved? In their quality improvement project, the investigators found that 38.6% of 44 genetic tests reviewed were inappropriately ordered—either they were not indicated (21%), misordered for false reassurance (7%), or inadequately ordered (10.5%). If the tests were ordered as appropriately recommended, a cost savings of $20,912.58 would have been realized, according to the researchers.

Ruzzo and colleagues reviewed 114 charts over a 3-month period for adherence with published clinical practice guidelines. All of the charts were associated with a genetic test billing code for common tests ordered through LabCorp (for cystic fibrosis, BRCA mutation, factor V Leiden, prothrombin, alpha-thalassemia, hemochromatosis, and cell-free DNA).

The researchers concluded that genetic counselor review or involvement in genetic test ordering can decrease inappropriate spending and improve patient care. They pointed out that the 114 charts reviewed represent a fraction of genetic tests ordered at their institution, and further study should broaden the research scope to determine the full extent of the problem.

Ruzzo and colleagues were awarded first prize for their research as presented at ACOG.

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Recommended Reading

Study sheds light on pregnancy outcomes following ocrelizumab treatment
MDedge ObGyn
OSA in pregnancy linked to congenital anomalies
MDedge ObGyn
Intra-amniotic sludge: Does its presence rule out cerclage for short cervix?
MDedge ObGyn
All isn’t well with HIV-exposed uninfected infants
MDedge ObGyn
Pregnancy and MS: How do they affect each other?
MDedge ObGyn
Brexanolone appears effective for severe postpartum depression
MDedge ObGyn
Breastfeeding may reduce moms’ stroke risk
MDedge ObGyn
ACIP approves new influenza vaccine recommendations
MDedge ObGyn
Narcotic analgesia for breastfeeding women
MDedge ObGyn
Labor and delivery mismanaged, child has CP: $30.5M award
MDedge ObGyn